Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 3 2Phase 1 2Phase NA 1Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Completed 20Recruiting 17Unknown 11Not yet recruiting 5Terminated 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Folfox protocol × Clear all
NCT01167725 2024-12-27

Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Terminated
340 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT01748851 2014-11-04

XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)

Dong-A University Hospital

Phase 3 Terminated
42 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡